Direct detection by the xpert MTB/RIF assay and characterization of multi and poly drug- resistant tuberculosis in Guinea-Bissau, West Africa

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Rabna, Paulo ^a   Ramos, Jorge ^b   Ponce, Gema ^b   Sanca, Lilica ^a   Mané, Morto ^a   Armada, Ana ^b   Machado, Diana ^b   Vieira, Fina ^c   Gomes, Victor F ^d   Martins, Elisabete ^c   Colombatti, Raffaella ^e   Riccardi, Fabio ^e   Perdigão, João ^f   Sotero, Joana ^f   Portugal, Isabel ^f   Couto, Isabel ^b   Atouguia, Jorge ^b   Rodrigues, Amabélia ^a   Viveiros, Miguel ^b  

^a Instituto Nacional de Saúde Pública Projecto de Saúde de Bandim INASA PSB   (Guinea-Bissau)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^c Hospital Raoul Follereau   (Guinea-Bissau)

^d Ministério da Saúde Programa Nacional de Luta Contra a Tuberculose   (Guinea-Bissau)

^e Health and Development Onlus Ahead Onlus   (Italy)

^f RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROSPECTIVE STUDY; RAPID TEST; RELIABILITY; SPUTUM ANALYSIS; DRUG EFFECTS; GENETICS; GUINEA-BISSAU; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; MUTATION; PATIENT SELECTION; PHYSIOLOGY; RISK; TIME FACTOR; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GUINEA-BISSAU; HUMANS; MALE; MOLECULAR TYPING; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PATIENT SELECTION; RIFAMPIN; RISK; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84958198245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127536     Document Type: Article

References (29)

1. World Health Organization. Global tuberculosis report 2014. WHO/HTM/TB/2014.08. Geneva, Switzerland: World Health Organization; 2014.
2. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2011.6. Geneva, Switzerland: World Health Organization; 2011.
3. Atun RA, Lebcir R, Drobniewski F, Coker RJ. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model. Int J STD AIDS. 2005; 16(8): 560-570. PMID: 16105192.
4. Drobniewski FA, Balabanova YM, Ruddy MC, Graham C, Kuznetzov SI, Gusarova GI, et al. Tuberculosis, HIV seroprevalence and intravenous and drug abuse in prisoners. Eur Respir J. 2008; 26(2): 298- 304.
5. World Health Organization. Global tuberculosis report 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: World Health Organization; 2013.
6. World Health Organization. Global tuberculosis control: surveillance, planning, is financing. WHO/HTH/TB/2008. Geneva, Switzerland: World Health Organization; 2008.
7. World Health Organization. Global Plan to Stop TB 2011-2015. WHO/HTM/STB/2010.2. Geneva, Switzerland: World Health Organization: 2010.
8. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010; 48(7): 2495-2501. doi:10.1128/JCM.00128-10 PMID: 20504986.
9. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system-policy statement. WHO/HTM/TB/2011.4. Geneva, Switzerland: World Health Organization; 2011.
10. World Health Organization. Global tuberculosis report 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: World Health Organization; 2012.
11. Steingart KA, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane database of systematic reviews, Issue 1: . Art. No.: CD009593. 2014; doi:10.1002/14651858.CD009593.pub3.
12. Ministério da Saúde da República da Guiné-Bissau. Programa Nacional de Luta contra a Tuberculose da República da Guiné-Bissau: plano estratégico II, 2009-2013; 2009.
13. Ministério da Saúde da República da Guiné-Bissau. Manual de Gestão do Programa Nacional De Luta Contra a Tuberculose da República da Guiné-Bissau; 2013.
14. World Health Organization. Treatment of tuberculosis: guidelines- 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: World Health Organization; 2009.
15. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2011.6. Geneva, Switzerland: World Health Organization; 2011.
16. Vieira F, Sanha MS, Riccardi F, Colombatti R. Short term advantages of a public-private partnership for tuberculosis in Guinea Bissau: reduction of mortality and increased diagnostic capacity. Mediterr J Hematol Infect Dis. 2014; 6(1): e2014049. doi:10.4084/MJHID.2014.049 PMID: 25045457.
17. International Air Transport Association. Infectious Substances Shipping Guidelines. Montreal, Canada: International Air Transport Association; 2006.
18. Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, Couto I, et al. Direct application of the INNO-LiPA Rif. TB line probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampicin resistance in 360 smear positive respiratory specimens from an area of high incidence of multi-drug resistant tuberculosis. J Clin Microbiol. 2005; 43(9): 4880-4884. PMID: 16145166.
19. Viveiros M, Martins M, Couto I, Rodrigues L, Machado D, Portugal I, et al. Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections. Expert Rev Anti Infect Ther. 2010; 8(4): 465-480. doi:10.1586/eri.10.20 PMID: 20377340.
20. Kent PT, Kubica GP. Mycobacteriology: A guide for the level III laboratory. Atlanta, Ga, USA: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control; 1985.
21. Siddiqi S, Rüsch-Gerdes S. MGIT960 procedure manual for BACTEC MGIT 960 TB system (also applicable for manual MGIT). Mycobacteria growth indicator tube (MGIT) culture and drug susceptibility demonstration projects. Foundation for innovative new diagnostics Ed; 2006.
22. Groenheit R, Ghebremichael S, Svensson J, Rabna P, Colombatti R, Riccardi F, et al. The Guinea-Bissau family of Mycobacterium tuberculosis complex revisited. PLoS ONE. 2011; 6(4): e18601. doi:10.1371/journal.pone.0018601 PMID: 21533101.
23. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006; 44(12): 4498-4510. PMID: 17005759.
24. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997; 35(4): 907-914. PMID: 9157152.
25. Shriver MD, Jin L, Boerwinkle E, Deka R, Ferrell RE, Chakraborty R. A novel measure of genetic distance for highly polymorphic tandem repeat loci. Mol Biol Evol. 1995; 12(5): 914-920. PMID: 7476137.
26. Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2008; 46(8): 2692- 2699. doi:10.1128/JCM.00540-08 PMID: 18550737.
27. Weniger T, Krawczyk J, Supply P, Niemann S, Harmsen D. MIRU-VNTRplus: A web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res. 2010; 38(2): W326- W331.
28. Demay C, Liens B, Burguière T, Hill V, Couvin D, Millet J, et al. SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012; 12(4): 755-766. doi:10.1016/j.meegid.2012.02.004 PMID: 22365971.
29. Machado D, Perdigão J, Ramos J, Couto I, Portugal I, Ritter C, et al. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations. J Antimicrob Chemother. 2013; 68(8): 1728-1732. doi:10.1093/jac/dkt090PMID:23539241.